NCT06047457

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2023-09-29Est. Completion: 2026-06-01

Enrollment target: 751 participants

Locations

Central Research Associates, Birmingham, Alabama, United States
CCT Research, Phoenix, Arizona, United States
HonorHealth Neurology, Scottsdale, Arizona, United States
Hope Clinical Research, LLC, Canoga Park, California, United States
Axiom Research LLC, Colton, California, United States
Fullerton Neurological Center, Fullerton, California, United States
Neurology Center of North Orange County, Fullerton, California, United States
SDS Clinical Trials, Orange, California, United States
Alliance Clinical San Diego (Acclaim Clinical Research), San Diego, California, United States
The Los Angeles Headache Center, Savannah, California, United States
Yale University School of Medicine, East Hartford, Connecticut, United States
Hasbani Neurology, New Haven, Connecticut, United States
New England Institute for Neurology and Headache (NEINH)/Medical Practice, Stamford, Connecticut, United States
Visionary Investigators Network (VIN), Aventura, Florida, United States
Velocity Clinical Research - Hallandale Beach, Hallandale, Florida, United States

MigraineMigraine Disorder

The goal of this clinical trial is to determine the effectiveness of Tai Chi training and acupuncture on the migraine at…

Hung Hom, Hong KongEst. completion Oct 31, 2026

Medication Overuse HeadacheElectroacupuncture

Acupuncture is commonly used for the prevention of migraine and tension-type headaches, and has been found to be effecti…

Beijing, ChinaEst. completion Dec 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.